Home > Publications database > Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignancies. > print |
001 | 301546 | ||
005 | 20250904144208.0 | ||
024 | 7 | _ | |a 10.1158/2643-3230.BCD-24-0328 |2 doi |
024 | 7 | _ | |a pmid:40402512 |2 pmid |
024 | 7 | _ | |a 2643-3230 |2 ISSN |
024 | 7 | _ | |a 2643-3249 |2 ISSN |
024 | 7 | _ | |a altmetric:177333643 |2 altmetric |
037 | _ | _ | |a DKFZ-2025-01067 |
041 | _ | _ | |a English |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Diamond, Benjamin |0 0000-0002-8638-9365 |b 0 |
245 | _ | _ | |a Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignancies. |
260 | _ | _ | |a Philadelphia, PA |c 2025 |b American Association for Cancer Research |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1756989533_27123 |2 PUB:(DE-HGF) |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
500 | _ | _ | |a 2025 Sep 3;6(5):450-463 / #EA:A360#LA:A360# |
520 | _ | _ | |a Ionizing radiotherapy (RT) is a widely used treatment strategy for malignancies. In solid tumors, RT-induced double-strand breaks lead to the accumulation of indels, and their repair by non-homologous end-joining has been linked to the ID8 mutational signature in surviving cells. However, the extent of RT-induced mutagenesis in hematologic malignancies and its impact on their mutational profiles and interplay with commonly used chemotherapies has not yet been explored. Here, we interrogated 580 whole-genome sequence samples (WGS) from patients with large B-cell lymphoma, multiple myeloma, and myeloid neoplasms and identified ID8 only in relapsed disease. Yet, ID8 was detected after exposure to both RT and mutagenic chemotherapy (i.e., platinum and melphalan). Using WGS of single-cell colonies derived from treated lymphoma cells, we revealed a dose-response relationship between RT and platinum and ID8. Finally, using ID8 as a genomic barcode we demonstrate that a single RT-surviving cell may seed distant relapse. |
536 | _ | _ | |a 311 - Zellbiologie und Tumorbiologie (POF4-311) |0 G:(DE-HGF)POF4-311 |c POF4-311 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
700 | 1 | _ | |a Chahar, Dhanvantri |0 0000-0002-7623-7018 |b 1 |
700 | 1 | _ | |a Jain, Michael D |0 0000-0002-7789-1257 |b 2 |
700 | 1 | _ | |a Poos, Alexandra |0 P:(DE-He78)b06e4e56845c7f91bd749bb7e6ac9d51 |b 3 |e First author |u dkfz |
700 | 1 | _ | |a Durante, Michael A |0 0000-0003-3137-6847 |b 4 |
700 | 1 | _ | |a Ziccheddu, Bachisio |0 0000-0002-2746-0053 |b 5 |
700 | 1 | _ | |a Kaddoura, Marcella |0 0000-0002-4529-7405 |b 6 |
700 | 1 | _ | |a Papadimitriou, Marios |0 0009-0009-1852-3495 |b 7 |
700 | 1 | _ | |a Maclachlan, Kylee H |0 0000-0001-7873-4854 |b 8 |
700 | 1 | _ | |a Jelinek, Tomas |0 0000-0002-5467-9253 |b 9 |
700 | 1 | _ | |a Davies, Faith E |0 0000-0002-3971-2393 |b 10 |
700 | 1 | _ | |a Figura, Nicholas B |0 0000-0002-6885-3320 |b 11 |
700 | 1 | _ | |a Morgan, Gareth J |0 0000-0002-4271-6360 |b 12 |
700 | 1 | _ | |a Mai, Elias K |0 0000-0002-6226-1252 |b 13 |
700 | 1 | _ | |a Weisel, Katja |0 0000-0001-9422-6614 |b 14 |
700 | 1 | _ | |a Fenk, Roland |0 0000-0001-7594-6288 |b 15 |
700 | 1 | _ | |a Raab, Marc-Steffen |0 P:(DE-He78)1cb537e833afd985097ccfaddffb2ef3 |b 16 |
700 | 1 | _ | |a Usmani, Saad |0 0000-0002-5484-8731 |b 17 |
700 | 1 | _ | |a Landgren, Ola |0 0000-0001-6485-4839 |b 18 |
700 | 1 | _ | |a Locke, Frederick L |0 0000-0001-9063-6691 |b 19 |
700 | 1 | _ | |a Goldschmidt, Hartmut |b 20 |
700 | 1 | _ | |a Schatz, Jonathan Harry |0 0000-0003-1842-228X |b 21 |
700 | 1 | _ | |a Weinhold, Niels |0 P:(DE-He78)66b39a79f3f922997656d7b902d324fb |b 22 |e Last author |u dkfz |
700 | 1 | _ | |a Maura, Francesco |0 0000-0002-5017-1620 |b 23 |
773 | _ | _ | |a 10.1158/2643-3230.BCD-24-0328 |0 PERI:(DE-600)3028898-8 |n 5 |p 450-463 |t Blood cancer discovery |v 6 |y 2025 |x 2643-3230 |
909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:301546 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)b06e4e56845c7f91bd749bb7e6ac9d51 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 16 |6 P:(DE-He78)1cb537e833afd985097ccfaddffb2ef3 |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 22 |6 P:(DE-He78)66b39a79f3f922997656d7b902d324fb |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-311 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Zellbiologie und Tumorbiologie |x 0 |
914 | 1 | _ | |y 2025 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BLOOD CANCER DISCOV : 2022 |d 2024-12-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2024-12-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2024-12-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2024-12-06 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0112 |2 StatID |b Emerging Sources Citation Index |d 2024-12-06 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2024-12-06 |
915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b BLOOD CANCER DISCOV : 2022 |d 2024-12-06 |
920 | 2 | _ | |0 I:(DE-He78)A360-20160331 |k A360 |l KKE Mol. Hämatologie/Onkologie |x 0 |
920 | 1 | _ | |0 I:(DE-He78)A360-20160331 |k A360 |l KKE Mol. Hämatologie/Onkologie |x 0 |
920 | 0 | _ | |0 I:(DE-He78)A360-20160331 |k A360 |l KKE Mol. Hämatologie/Onkologie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)A360-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|